Bevacizumab In Hereditary Hemorrhagic Telangiectasia
Condition(s):Hereditary Hemorrhagic TelangiectasiaLast Updated:May 1, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Hereditary Hemorrhagic TelangiectasiaLast Updated:May 1, 2023Recruiting
Condition(s):Hereditary Hemorrhagic TelangiectasiaLast Updated:July 17, 2023Recruiting
Condition(s):Hereditary Hemorrhagic Telangiectasia (HHT)Last Updated:March 5, 2024Active, not recruiting
Condition(s):Hereditary Hemorrhagic TelangiectasiaLast Updated:March 2, 2023Completed
Condition(s):Hereditary Hemorrhagic TelangiectasiaLast Updated:March 6, 2024Recruiting
Condition(s):Hereditary Hemorrhagic TelangiectasiaLast Updated:August 24, 2021Completed
Condition(s):Hereditary Hemorrhagic TelangiectasiaLast Updated:November 20, 2020Completed
Condition(s):Hereditary Hemorrhagic TelangiectasiaLast Updated:December 15, 2009Completed
Condition(s):Hereditary Hemorrhagic Telangiectasia (HHT)Last Updated:December 4, 2019Completed
Condition(s):Hereditary Hemorrhagic Telangiectasia; Epistaxis NosebleedLast Updated:July 18, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.